Lifeist Wellness Inc. (LFST.V)
CAD 0.05
(-10.0%)
CAD 0.05
(-10.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.58 CAD | 21.62% |
| 2022 | -0.74 CAD | 39.34% |
| 2021 | -1.22 CAD | 24.69% |
| 2020 | -1.62 CAD | 58.99% |
| 2019 | -3.95 CAD | -120.67% |
| 2018 | -1.79 CAD | 27.82% |
| 2017 | -2.48 CAD | -244.44% |
| 2016 | -0.72 CAD | -460.0% |
| 2015 | 0.20 CAD | 117.24% |
| 2014 | -1.16 CAD | -544.44% |
| 2013 | -0.18 CAD | 35.71% |
| 2012 | -0.28 CAD | 80.14% |
| 2011 | -1.41 CAD | -156.36% |
| 2010 | -0.55 CAD | -34.15% |
| 2009 | -0.41 CAD | -70.83% |
| 2008 | -0.24 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.09 CAD | 61.17% |
| 2024 Q3 | -0.05 CAD | 297.7% |
| 2024 Q2 | -0.05 CAD | 46.36% |
| 2023 Q3 | -0.10 CAD | -2.67% |
| 2023 Q2 | -0.10 CAD | 35.13% |
| 2023 Q1 | -0.15 CAD | 60.53% |
| 2023 FY | - CAD | 21.62% |
| 2023 Q4 | -0.23 CAD | -130.23% |
| 2022 Q4 | -0.38 CAD | -305.12% |
| 2022 Q2 | -0.19 CAD | 13.64% |
| 2022 Q1 | -0.22 CAD | 0.0% |
| 2022 FY | - CAD | 39.34% |
| 2022 Q3 | -0.09 CAD | 50.63% |
| 2021 Q4 | -0.22 CAD | 29.03% |
| 2021 Q2 | -0.32 CAD | 21.95% |
| 2021 Q1 | -0.41 CAD | -5.13% |
| 2021 FY | - CAD | 24.69% |
| 2021 Q3 | -0.31 CAD | 3.13% |
| 2020 Q2 | -0.30 CAD | 33.33% |
| 2020 Q1 | -0.45 CAD | 75.41% |
| 2020 Q3 | -0.48 CAD | -60.0% |
| 2020 Q4 | -0.39 CAD | 18.75% |
| 2020 FY | - CAD | 58.99% |
| 2019 Q3 | -0.91 CAD | -68.52% |
| 2019 Q1 | -0.66 CAD | 42.11% |
| 2019 Q2 | -0.54 CAD | 18.18% |
| 2019 Q4 | -1.83 CAD | -101.1% |
| 2019 FY | - CAD | -120.67% |
| 2018 Q1 | -0.26 CAD | 10.34% |
| 2018 FY | - CAD | 27.82% |
| 2018 Q4 | -1.14 CAD | -86.89% |
| 2018 Q3 | -0.61 CAD | -3.39% |
| 2018 Q2 | -0.59 CAD | -126.92% |
| 2017 Q2 | -0.53 CAD | -96.3% |
| 2017 Q1 | -0.27 CAD | -35.0% |
| 2017 FY | - CAD | -244.44% |
| 2017 Q4 | -0.29 CAD | 76.42% |
| 2017 Q3 | -1.23 CAD | -132.08% |
| 2016 Q4 | -0.20 CAD | 41.18% |
| 2016 Q2 | -0.12 CAD | -71.43% |
| 2016 FY | - CAD | -460.0% |
| 2016 Q1 | -0.07 CAD | -255.33% |
| 2016 Q3 | -0.34 CAD | -183.33% |
| 2015 FY | - CAD | 117.24% |
| 2015 Q4 | -0.02 CAD | -134.52% |
| 2015 Q3 | -0.01 CAD | 48.15% |
| 2015 Q2 | -0.02 CAD | 92.64% |
| 2015 Q1 | -0.22 CAD | -212.94% |
| 2014 Q4 | -0.07 CAD | 49.79% |
| 2014 FY | - CAD | -544.44% |
| 2014 Q3 | -0.14 CAD | -16.67% |
| 2014 Q1 | -0.09 CAD | -408.14% |
| 2014 Q2 | -0.12 CAD | -37.3% |
| 2013 Q4 | -0.02 CAD | 56.35% |
| 2013 FY | - CAD | 35.71% |
| 2013 Q1 | -0.04 CAD | 15.28% |
| 2013 Q2 | -0.04 CAD | 3.87% |
| 2013 Q3 | -0.04 CAD | -5.63% |
| 2012 Q4 | -0.05 CAD | 29.97% |
| 2012 Q1 | -1.17 CAD | -680.0% |
| 2012 FY | - CAD | 80.14% |
| 2012 Q3 | -0.07 CAD | 49.69% |
| 2012 Q2 | -0.13 CAD | 88.89% |
| 2011 Q1 | -0.27 CAD | -386.49% |
| 2011 Q3 | -0.16 CAD | -60.0% |
| 2011 FY | - CAD | -156.36% |
| 2011 Q2 | -0.10 CAD | 62.96% |
| 2011 Q4 | -0.15 CAD | 6.25% |
| 2010 FY | - CAD | -34.15% |
| 2010 Q3 | -0.11 CAD | 8.33% |
| 2010 Q2 | -0.12 CAD | -26.18% |
| 2010 Q1 | -0.10 CAD | -301.27% |
| 2010 Q4 | -0.06 CAD | 49.55% |
| 2009 FY | - CAD | -70.83% |
| 2009 Q3 | -0.34 CAD | -61.9% |
| 2009 Q4 | -0.02 CAD | 93.03% |
| 2009 Q2 | -0.21 CAD | 83.72% |
| 2009 Q1 | -1.29 CAD | -171.67% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | 1.80 CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -0.02 CAD | -2489.286% |
| CanadaBis Capital Inc. | 0.03 CAD | 1890.123% |
| Decibel Cannabis Company Inc. | -0.00 CAD | -13388.372% |
| Delivra Health Brands Inc. | 0.00 CAD | 18809.677% |
| Entourage Health Corp. | -0.15 CAD | -286.667% |
| Cannara Biotech Inc. | 0.08 CAD | 845.501% |
| Medicure Inc. | -0.09 CAD | -556.852% |
| PharmaCielo Ltd. | -0.10 CAD | -480.0% |
| Rubicon Organics Inc. | -0.03 CAD | -1695.666% |
| BioSyent Inc. | 0.54 CAD | 207.407% |
| Voyageur Pharmaceuticals Ltd. | -0.01 CAD | -5320.561% |